DEXTROSE; POTASSIUM CHLORIDE; SODIUM CHLORIDE - Generic Drug Details

What are the generic sources for dextrose; potassium chloride; sodium chloride and what is the scope of freedom to operate?

Dextrose; potassium chloride; sodium chloride is the generic ingredient in one hundred and thirteen branded drugs marketed by B Braun, Baxter Hlthcare, Fresenius Kabi Usa, Otsuka Icu Medcl, and Icu Medical Inc, and is included in thirteen NDAs. Additional information is available in the individual branded drug profile pages.

Four suppliers are listed for this compound.

Summary for DEXTROSE; POTASSIUM CHLORIDE; SODIUM CHLORIDE

US Patents:	0
Tradenames:	113
Applicants:	5
NDAs:	13
Finished Product Suppliers / Packagers:	4
DailyMed Link:	DEXTROSE; POTASSIUM CHLORIDE; SODIUM CHLORIDE at DailyMed

Pharmacology for DEXTROSE; POTASSIUM CHLORIDE; SODIUM CHLORIDE

Drug Class	Osmotic Laxative Potassium Salt
Mechanism of Action	Osmotic Activity
Physiological Effect	Increased Large Intestinal Motility Inhibition Large Intestine Fluid/Electrolyte Absorption

Anatomical Therapeutic Chemical (ATC) Classes for DEXTROSE; POTASSIUM CHLORIDE; SODIUM CHLORIDE

A12BA	Potassium
A12B	POTASSIUM
A12	MINERAL SUPPLEMENTS
A	Alimentary tract and metabolism

A12CA	Sodium
A12C	OTHER MINERAL SUPPLEMENTS
A12	MINERAL SUPPLEMENTS
A	Alimentary tract and metabolism

B05CB	Salt solutions
B05C	IRRIGATING SOLUTIONS
B05	BLOOD SUBSTITUTES AND PERFUSION SOLUTIONS
B	Blood and blood forming organs

B05XA	Electrolyte solutions
B05X	I.V. SOLUTION ADDITIVES
B05	BLOOD SUBSTITUTES AND PERFUSION SOLUTIONS
B	Blood and blood forming organs

B05XA	Electrolyte solutions
B05X	I.V. SOLUTION ADDITIVES
B05	BLOOD SUBSTITUTES AND PERFUSION SOLUTIONS
B	Blood and blood forming organs

US Patents and Regulatory Information for DEXTROSE; POTASSIUM CHLORIDE; SODIUM CHLORIDE

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
B Braun	POTASSIUM CHLORIDE 0.075% IN DEXTROSE 3.3% AND SODIUM CHLORIDE 0.3% IN PLASTIC CONTAINER	dextrose; potassium chloride; sodium chloride	INJECTABLE;INJECTION	019630-049	May 7, 1992		RX	No	No
Baxter Hlthcare	DEXTROSE 5%, SODIUM CHLORIDE 0.33% AND POTASSIUM CHLORIDE 20MEQ IN PLASTIC CONTAINER	dextrose; potassium chloride; sodium chloride	INJECTABLE;INJECTION	018629-004	Mar 23, 1982	AP	RX	No	No
Otsuka Icu Medcl	POTASSIUM CHLORIDE 10MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER	dextrose; potassium chloride; sodium chloride	INJECTABLE;INJECTION	019691-004	Mar 24, 1988		DISCN	Yes	No
B Braun	POTASSIUM CHLORIDE 0.11% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER	dextrose; potassium chloride; sodium chloride	INJECTABLE;INJECTION	019630-021	Feb 17, 1988		RX	No	No
Otsuka Icu Medcl	POTASSIUM CHLORIDE 10MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER	dextrose; potassium chloride; sodium chloride	INJECTABLE;INJECTION	018362-005	Mar 28, 1988	AP	RX	Yes	Yes

DEXTROSE; POTASSIUM CHLORIDE; SODIUM CHLORIDE Market Analysis and Financial Projection

Last updated: February 13, 2026

What Are the Market Dynamics for Dextrose, Potassium Chloride, and Sodium Chloride?

The market for intravenous (IV) solutions containing dextrose, potassium chloride, and sodium chloride is driven by several factors including healthcare infrastructure expansion, pharmaceutical manufacturing demand, and global health needs.

Market Size and Growth

The global IV fluids market was valued at approximately $15.7 billion in 2020 and is projected to reach $23.5 billion by 2028, growing at a CAGR of around 5.2% (2021–2028). The volume of sales for dextrose, potassium chloride, and sodium chloride solutions accounts for over 60% of this market, underlining their fundamental role in clinical settings.

Key Drivers

• Rising hospitalization rates: Increased incidences of chronic diseases, trauma, and surgical procedures elevate the demand for IV fluids.
• Growing aging population: The elderly have higher hydration and electrolyte management needs.
• Expanding healthcare infrastructure: Emerging markets invest in hospital expansions, increasing demand for IV therapies.
• Supply chain stability: Ongoing disruptions influence manufacturing and distribution capabilities.

Market Segmentation

• By Application: Hydration therapy, electrolyte replacement, nutrition support.
• By End-User: Hospitals (about 65%), clinics, home healthcare providers.
• By Geography: North America (largest share), Europe, Asia-Pacific (fastest-growing segment).

What Are the Key Financial Trends and Revenue Dynamics?

Revenue Distribution

• North America: Dominates with approximately 45% of global sales, driven by high healthcare expenditure.
• Europe: Approx. 25% market share; growth influenced by aging populations.
• Asia-Pacific: Near 20%; rapid expansion due to healthcare infrastructure investment.

Pricing Trends

Price variation exists based on formulation (sterile, hypertonic, isotonic), volume, and supplier. The average price for a standard 1000 mL bag varies:

• Sodium chloride: $2–$5
• Dextrose solutions: $3–$6
• Potassium chloride (per 10 mmol dose): $0.50–$2

Increased regulatory scrutiny and raw material costs have led to recent price increases in some regions.

R&D and Market Entry

Limited innovation exists due to the mature nature of these commodities, but biosimilar entries and alternative electrolyte formulations may influence future competitiveness. Large pharmaceutical suppliers maintain dominant market shares through established manufacturing and distribution channels.

What Are the Future Outlooks in Terms of Technology and Investment?

Technological Advances

• Development of stabilized formulations with extended shelf life.
• Integration of smart infusion pumps for precise electrolyte monitoring.
• Adoption of single-use, pre-filled IV bags to minimize contamination.

Investment Trends

• Capital expenditure in manufacturing capacity exceeds $1 billion globally in the next five years.
• Mergers and acquisitions focus on regional players and specialty electrolyte solutions.
• Regulatory pressures push for product standardization and quality assurance.

Potential Disruptors

• Supply chain vulnerabilities for raw materials.
• Price pressures from generic and regional manufacturers.
• Increased regulatory standards—particularly for sterile manufacturing practices.

What Are the Challenges Limiting Market Growth?

• Sustainability concerns in raw material sourcing, especially sodium and potassium.
• Price sensitivity in healthcare budgets.
• Regulatory approvals prolonging time-to-market for new formulations.

Key Takeaways

• The IV solutions market involving dextrose, potassium chloride, and sodium chloride forms a core segment of global health infrastructure.
• North America leads demand, but Asia-Pacific emerges as a fastest-growing region.
• Market growth sustains through healthcare expansion, aging populations, and technological improvements.
• Pricing fluctuations arise from raw material costs and regulatory changes.
• Limited innovation characterizes these mature markets, though some technological integration and manufacturing efficiencies are underway.

FAQs

1. How does geopolitical instability impact the supply of these electrolytes?
Disruptions in raw material supply chains and international trade tensions can lead to shortages or increased costs, influencing overall availability and pricing.

2. Are there notable regulatory changes affecting this market?
Yes. Agencies like the FDA and EMA enforce strict manufacturing standards, which may impact production costs and timelines for new formulations.

3. What is the growth potential in emerging markets?
Growing healthcare infrastructure, increasing disease prevalence, and rising health expenditures support double-digit growth projections in regions like Asia-Pacific.

4. How significant is innovation in this mature market?
Innovation primarily focuses on formulation stability, infusion device integration, and improving sterile manufacturing processes rather than new electrolyte types.

5. Who are the leading manufacturers?
Companies like Baxter International, B. Braun Melsungen, and Fresenius Kabi dominate the market, accounting for approximately 60% of global sales.

Cited Sources

1. MarketsandMarkets. "Intravenous (IV) Fluid Market by Type, Application, and Region." 2022.
2. Grand View Research. "IV Fluid Market Size, Share & Trends Analysis," 2021.
3. Statista. "Global IV Fluid Revenue Forecast," 2022.
4. U.S. Food and Drug Administration. "Regulatory Requirements for IV Solution Manufacturing," 2022.
5. Industry Reports. "Electrolyte Solutions Market Overview," 2022.